Limei Han
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Infectious Diseases top 5%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- DNA Repair Mechanisms 3
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 3
-
- Allelopathy and phytotoxic interactions 7
- Co-authors
- Jianxin Wang (9 shared papers)Xiaoling Fang (6 shared papers)Jing Qin (6 shared papers)Keiko Muraki (3 shared papers)John P. Murnane (3 shared papers)Hai Chen (2 shared papers)Xiaoying Fu (2 shared papers)Yi Wang (2 shared papers)
- Journals
- Drug Delivery (3 papers)Fitoterapia (2 papers)Frontiers in Neurology (2 papers)Research in Veterinary Science (2 papers)Advances in experimental medicine and biology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Limei Han
54 papers receiving 1.4k citations
Limei Han's Hit Papers
Peers
Comparison fields: 5 of 113
- Biomaterials 249
- Infectious Diseases 295
- Pharmaceutical Science 86
- Aging 23
- Biomedical Engineering 434
Countries citing papers authored by Limei Han
This map shows the geographic impact of Limei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Han more than expected).
Fields of papers citing papers by Limei Han
This network shows the impact of papers produced by Limei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Han. The network helps show where Limei Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19 Hit paper breakdown → | 2020 | 369 |
| 2 | 2012 | 123 | |
| 3 | 2006 | 93 | |
| 4 | 2017 | 90 | |
| 5 | 2012 | 87 | |
| 6 | 2013 | 81 | |
| 7 | 2012 | 54 | |
| 8 | 2013 | 53 | |
| 9 | 2012 | 47 | |
| 10 | 2009 | 34 | |
| 11 | 2012 | 33 | |
| 12 | 2013 | 25 | |
| 13 | 2019 | 24 | |
| 14 | 2016 | 23 | |
| 15 | 2019 | 20 | |
| 16 | 2024 | 18 | |
| 17 | 2015 | 15 | |
| 18 | 2015 | 14 | |
| 19 | 2014 | 14 | |
| 20 | 2021 | 11 |
About Limei Han
Limei Han is a scholar working on Molecular Biology, Plant Science, Pharmacology, Physiology and Oncology, having authored 60 papers that have together received 1.4k indexed citations. Recurring topics across this work include Allelopathy and phytotoxic interactions (7 papers), DNA Repair Mechanisms (3 papers), RNA Interference and Gene Delivery (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Plant-based Medicinal Research (3 papers), Antimicrobial Peptides and Activities (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Biomaterials (249 citations), Infectious Diseases (295 citations), Pharmaceutical Science (86 citations), Aging (23 citations) and Biomedical Engineering (434 citations). Limei Han has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jianxin Wang, Xiaoling Fang, Jing Qin, Keiko Muraki, John P. Murnane, Hai Chen, Xiaoying Fu, Yi Wang, Shaojin Chen and Sha Li. Their work appears in journals such as Drug Delivery, Fitoterapia, Frontiers in Neurology, Research in Veterinary Science and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.